Skip to content

Meet our team attending ASCO

Alastair MacDonald

Head of Medical Affairs and Growth Strategy

Medical affairs
Chris Appleby

Director of Oncology Services

Professor Chris Nutting

Medical Assurance Director • Professional Standards Regulatory Affairs and Patient Safety

Care that connects: experiences from patients and clinicians

patient support programs

Accelerate access. Extend adherence. Deliver value.  

Getting patients on treatment fast – and keeping them on it – is one of the greatest clinical and commercial challenges in oncology treatment. 

Whether you’re launching a new therapy, scaling market access across Europe, or supporting real-world evidence generation, Sciensus delivers the infrastructure and expertise to help you reach patients  where they are – and keep them supported and compliant.  

Leveraging over 30 years of clinical experience, deep therapeutic expertise, and personalised digital innovation, we help biopharma and healthcare systems bring oncology treatments to patients.  

Learn more

Sciensus will be attending the upcoming ASCO (American Society of Clinical Oncology) 

ASCO is one of the most influential events in oncology, bringing together global leaders in cancer research, clinical practice, and patient care to advance the future of oncology treatment. 

Join us in Chicago to discover your trusted European end-to-end partner for oncology and specialty medicines. 

Sciensus

About Sciensus

Sciensus is a European leader in integrated end-to-end commercial services, supporting patients, health systems, providers and Biopharma companies. We offer distribution services, clinical care, digital solutions and patient insights to accelerate access to medicines and maximise product launches from clinical to full commercialisation. With over 30 years’ experience navigating the complex European healthcare ecosystem, Sciensus helps bring the right medicine to the right patients – faster.

Learn more